• Publications
  • Tunnel vision or global outlook? Global Pharm...
Published on 16 Jul 2020

Tunnel vision or global outlook? Global Pharma's preoccupation with the US.

COVID-19 is a litmus test of whether health systems can pool assets and expertise and fairly distribute resources so that patients worldwide can benefit equally, writes Jayasree K. Iyer, Executive Director of the Access to Medicine Foundation. 

Explore further

Back to top |